Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and ...

Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease.

SHANNON, CLARE, IRELAND, February 27, 2026 /EINPresswire.com/ -- Announcing a new publication from Opto-Electronic ...

Nuclear magnetic resonance –based co-magnetometers are essential tools for applications ranging from inertial navigation to geophysical exploration and biomedical sensing. Their performance critically ...

The convergence of CNS and oncology research amplifies the significance of Oncotelic’s recent intellectual property updates for OT-101. Developed in collaboration with Sapu Bioscience, the expanded ...

iSCIB1+ shows an interim 24%-point improvement in progression free survival (PFS) over real world SoC and historic controls NOTTINGHAM, United Kingdom, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Scancell ...

Abstract: A simple analysis technique of cross gain modulation and cross phase modulation in SOA using delayed interferometer configuration was proposed. Recovery time and the amounts of XGM and XPM ...

LONDON, Jan 14 (Reuters) - A group of the world's leading central banks and over 40 major commercial banks are to step up testing of one of world's most closely watched digital payments projects, as ...

Ripple announced a two-phase zero-knowledge privacy roadmap for XRPL in October 2025, targeting institutional adoption by mid-2026. Phase 1 enables private, compliant transactions using zero-knowledge ...

XRP formed a death cross as its 50-day moving average crossed below the 200-day average for the first time since May 2025. Analysts expect XRP to drop into the $1.80 to $2.10 range if it breaks below ...